306 related articles for article (PubMed ID: 26514449)
21. [Prognostic factors and outcome of esthesioneuroblastoma].
Zhao LJ; Gao L; Xu GZ; Li SY; Xiao GL
Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):561-4. PubMed ID: 16438858
[TBL] [Abstract][Full Text] [Related]
22. Esthesioneuroblastoma treated with non-craniofacial resection surgery followed by combined chemotherapy and radiotherapy: An alternative approach in limited resources.
Rastogi M; Bhatt M; Chufal K; Srivastava M; Pant M; Srivastava K; Mehrotra S
Jpn J Clin Oncol; 2006 Oct; 36(10):613-9. PubMed ID: 16926225
[TBL] [Abstract][Full Text] [Related]
23. Esthesioneuroblastoma in pediatric and adolescent age. A report from the TREP project in cooperation with the Italian Neuroblastoma and Soft Tissue Sarcoma Committees.
Bisogno G; Soloni P; Conte M; Podda M; Ferrari A; Garaventa A; Luksch R; Cecchetto G
BMC Cancer; 2012 Mar; 12():117. PubMed ID: 22443159
[TBL] [Abstract][Full Text] [Related]
24. Esthesioneuroblastoma: the Northwestern University experience.
Argiris A; Dutra J; Tseke P; Haines K
Laryngoscope; 2003 Jan; 113(1):155-60. PubMed ID: 12514401
[TBL] [Abstract][Full Text] [Related]
25. Esthesioneuroblastoma: irradiation alone and surgery alone are not enough.
Gruber G; Laedrach K; Baumert B; Caversaccio M; Raveh J; Greiner R
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):486-91. PubMed ID: 12243826
[TBL] [Abstract][Full Text] [Related]
26. Olfactory neuroblastoma: the long-term outcome and late toxicity of multimodal therapy including radiotherapy based on treatment planning using computed tomography.
Mori T; Onimaru R; Onodera S; Tsuchiya K; Yasuda K; Hatakeyama H; Kobayashi H; Terasaka S; Homma A; Shirato H
Radiat Oncol; 2015 Apr; 10():88. PubMed ID: 25888953
[TBL] [Abstract][Full Text] [Related]
27. Esthesioneuroblastoma: a Danish demographic study of 40 patients registered between 1978 and 2000.
Theilgaard SA; Buchwald C; Ingeholm P; Kornum Larsen S; Eriksen JG; Sand Hansen H
Acta Otolaryngol; 2003 Apr; 123(3):433-9. PubMed ID: 12737303
[TBL] [Abstract][Full Text] [Related]
28. Surgical treatment versus concurrent chemoradiotherapy as an initial treatment modality in advanced olfactory neuroblastoma.
Kim HJ; Kim CH; Lee BJ; Chung YS; Kim JK; Choi YS; Yoon JH
Auris Nasus Larynx; 2007 Dec; 34(4):493-8. PubMed ID: 17499464
[TBL] [Abstract][Full Text] [Related]
29. Outcome and prognostic factors in olfactory neuroblastoma: a rare cancer network study.
Ozsahin M; Gruber G; Olszyk O; Karakoyun-Celik O; Pehlivan B; Azria D; Roelandts M; Kaanders JH; Cengiz M; Krengli M; Matzinger O; Zouhair A
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):992-7. PubMed ID: 20231062
[TBL] [Abstract][Full Text] [Related]
30. Esthesioneuroblastoma: the role of adjuvant radiation therapy.
Foote RL; Morita A; Ebersold MJ; Olsen KD; Lewis JE; Quast LM; Ferguson JA; O'Fallon WM
Int J Radiat Oncol Biol Phys; 1993 Nov; 27(4):835-42. PubMed ID: 8244813
[TBL] [Abstract][Full Text] [Related]
31. Olfactory neuroblastoma: the University of Erlangen-Nuremberg experience 1975-2000.
Constantinidis J; Steinhart H; Koch M; Buchfelder M; Schaenzer A; Weidenbecher M; Iro H
Otolaryngol Head Neck Surg; 2004 May; 130(5):567-74. PubMed ID: 15138422
[TBL] [Abstract][Full Text] [Related]
32. Long-Term Prognostic Analysis after Endoscopic Endonasal Surgery for Olfactory Neuroblastoma: A Retrospective Study of 13 Cases.
Zhang L; Niu K; Zhu K; Xia C; Yan J; Zhao W; Wei J; Duan M; Zheng G
PLoS One; 2016; 11(11):e0166046. PubMed ID: 27806104
[TBL] [Abstract][Full Text] [Related]
33. Esthesioneuroblastoma of the nasal cavity.
Hollen TR; Morris CG; Kirwan JM; Amdur RJ; Werning JW; Vaysberg M; Mendenhall WM
Am J Clin Oncol; 2015 Jun; 38(3):311-4. PubMed ID: 23822985
[TBL] [Abstract][Full Text] [Related]
34. Esthesioneuroblastoma: continued follow-up of a single institution's experience.
Loy AH; Reibel JF; Read PW; Thomas CY; Newman SA; Jane JA; Levine PA
Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):134-8. PubMed ID: 16490869
[TBL] [Abstract][Full Text] [Related]
35. [Clinical analysis of 34 cases of esthesioneuroblastoma].
Liu WS; Tang PZ; Xu GZ
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Jun; 39(6):328-32. PubMed ID: 15469075
[TBL] [Abstract][Full Text] [Related]
36. Long-term outcomes of patients with esthesioneuroblastomas: A cohort from a single institution.
Yin ZZ; Gao L; Luo JW; Yi JL; Huang XD; Qu Y; Wang K; Zhang SP; Xiao JP; Xu GZ; Li YX
Oral Oncol; 2016 Feb; 53():48-53. PubMed ID: 26712253
[TBL] [Abstract][Full Text] [Related]
37. Esthesioneuroblastoma. Long-term outcome and patterns of failure--the University of Virginia experience.
Eden BV; Debo RF; Larner JM; Kelly MD; Levine PA; Stewart FM; Cantrell RW; Constable WC
Cancer; 1994 May; 73(10):2556-62. PubMed ID: 8174053
[TBL] [Abstract][Full Text] [Related]
38. Intracavitary chemotherapy (Gliadel) for recurrent esthesioneuroblastoma: case report and review of the literature.
Park MC; Weaver CE; Donahue JE; Sampath P
J Neurooncol; 2006 Mar; 77(1):47-51. PubMed ID: 16283436
[TBL] [Abstract][Full Text] [Related]
39. [Prognostic factors in childhood sarcomas of neuroectodermal histogenesis].
Budarin MA
Vopr Onkol; 2002; 48(3):335-9. PubMed ID: 12455358
[No Abstract] [Full Text] [Related]
40. Esthesioneuroblastoma: a case report.
Shukla RC; Singh PK; Senthil S; Pathak R
Nepal Med Coll J; 2010 Jun; 12(2):128-32. PubMed ID: 21222414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
